XML 45 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivative Financial Instruments (Narrative) (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Gains or losses on derivative instruments, statement of income          
Ineffectiveness - amount of gain (losses) recognized in income on related hedged items $ (151,000) $ (1,600,000) $ 145,000 $ 17,000  
Derivative, Excluded Component, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of Goods Sold. Cost of Goods Sold. Cost of Goods Sold. Cost of Goods Sold.  
Gain excluded from hedge effectiveness testing $ 817,000 $ 1,300,000 $ 1,900,000 $ 3,200,000  
Amount of gain (loss) related to cash flow hedges 10,000,000.0 (2,300,000) 6,800,000 41,800,000  
Net gains (losses) reclassified (7,100,000) $ 23,200,000 (7,700,000) $ 30,400,000  
Price Risk Cash Flow Hedge Unrealized Gain (Loss) to be Reclassified During Next 12 Months (3,600,000)   $ (3,600,000)    
Period Within Which The Company Expects To Reclassify Net Gains On Derivative Instruments From AOCI to Earnings     12 months    
Futures | Commodity contract          
Commodity contract commitments          
Fair value of derivatives including required margin deposits $ 13,000,000.0   $ 13,000,000.0   $ 24,900,000
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other Assets, Current   Other Assets, Current   Other Assets, Current